A5019272458- Thyroid Disorders and Treatments
- SARS-CoV-2 detection and testing
- Thyroid Cancer Diagnosis and Treatment
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Neuroendocrine Tumor Research Advances
- Biosensors and Analytical Detection
- Pituitary Gland Disorders and Treatments
Abbott (United States)
2020-2023
Abbott Fund
2022
Abstract Background Thyroglobulin (Tg) is an essential part for the management of patients with differentiated thyroid carcinoma (DTC) after thyroidectomy. Highly sensitive Tg assays are now established in clinical practice as they facilitate follow‐up DTC patients. In this study, we evaluated recently launched highly Abbott assay Alinity and ARCHITECT. Methods three‐center values 447 routine patient samples, characterized presence anti‐Tg, were measured ARCHITECT compared Roche Elecsys TgII...
Abstract Introduction Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is diagnosed molecular-based detection of SARS-CoV-2 RNA. Serologic testing detects antibodies specific to and IgM specifically may serve as an adjunct test PCR early in disease. We evaluated the Abbott anti-SARS-CoV-2 IgG assays along with DiaSorin Roche Total. Methods Specimens from 175 PCR-positive patients 107 control specimens were analyzed using IgG, Total...